« Return to News | R&D Trends

BioCity Scotland secures former MSD site

Wednesday, January 18, 2012 12:09 PM

Newly-formed BioCity Scotland, a centralized base for growing bioscience, pharameutical, med tech and health companies, will set up house in the former-MSD research facility at Newhouse, which it acquired Jan. 11.

A joint venture between BioCity Nottingham and Roslin BioCentre, BioCity Scotland will be 15 miles from Glasgow and 33 miles from Edinburgh, a central location for growing companies in Scotland.

The 130,000-square-foot facility consists of purpose-built labs and offices on 23 acres and is capable of supporting pre-clinical drug discovery and development by a range of independent companies. It is equipped with administrative and conference facilities to provide support and networking capabilities for client companies.

BioCity Scotland will provide access to a range of state-of-the-art equipment, available to rent at competitive rates. On-site business support will allow companies to tap into funding opportunities to assist their growing business needs.

“BioCity Scotland is much more than a property proposition—it will be a unique, vibrant community of scientific companies,” said Louis J. Nisbet, chairman of BioCity Scotland. “BioCity Nottingham's success in nurturing and growing over 70 new companies since 2003, and Roslin's expertise in life sciences innovation and facilities management makes this team the perfect commercial partnership."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.